Tapewire

Nasdaq · USD

AURA

Aura Biosciences, Inc.

Export transactions ↓
Tapewire entity
5142
SEC CIK
0001501796
Parsed reports
136

Last 12 months

Inside the activity.

0 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202602
Feb 202605
Mar 202600
Apr 202601
May 202601
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 01, 2026 Filed Sep 1, 2026 21:23 UTC
Elazzouzi AmySVP, Finance & PAO
GrantStock Option (Right to Buy) · Derivative 46,460 $0.00 Strike: $7.43 $0.00
Disclosure

SEC source: 0002042910-26-000003 · form4-09012026_090904.xml · derivative · entry 2

Elazzouzi Amy · CIK 0002042910 · SVP, Finance & PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,460

Underlying: Common Stock · 46,460 shares

Expires 2036-09-01

F2 · derivative.exercise_date: The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:23 UTC
Elazzouzi AmySVP, Finance & PAO
GrantCommon Stock 23,540 $0.00 $0.00
Disclosure

SEC source: 0002042910-26-000003 · form4-09012026_090904.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · SVP, Finance & PAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,600

F1 · shares: The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:28 UTC
Person JulieChief People Officer
GrantStock Option (Right to Buy) · Derivative 212,389 $0.00 Strike: $7.43 $0.00
Disclosure

SEC source: 0001946505-26-000009 · form4-09012026_090914.xml · derivative · entry 2

Person Julie · CIK 0001946505 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,389

Underlying: Common Stock · 212,389 shares

Expires 2036-09-01

F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:28 UTC
Person JulieChief People Officer
GrantCommon Stock 107,611 $0.00 $0.00
Disclosure

SEC source: 0001946505-26-000009 · form4-09012026_090914.xml · nonDerivative · entry 1

Person Julie · CIK 0001946505 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,611

F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:26 UTC
Kratz EricaChief Reg. & Quality Officer
GrantStock Option (Right to Buy) · Derivative 199,115 $0.00 Strike: $7.43 $0.00
Disclosure

SEC source: 0002148785-26-000009 · form4-09012026_090933.xml · derivative · entry 2

Kratz Erica · CIK 0002148785 · Chief Reg. & Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 199,115

Underlying: Common Stock · 199,115 shares

Expires 2036-09-01

F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:26 UTC
Kratz EricaChief Reg. & Quality Officer
GrantCommon Stock 100,885 $0.00 $0.00
Disclosure

SEC source: 0002148785-26-000009 · form4-09012026_090933.xml · nonDerivative · entry 1

Kratz Erica · CIK 0002148785 · Chief Reg. & Quality Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,885

F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:24 UTC
Hopkins Janet JillChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 116,150 $0.00 Strike: $7.43 $0.00
Disclosure

SEC source: 0001997710-26-000004 · form4-09012026_090929.xml · derivative · entry 2

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,150

Underlying: Common Stock · 116,150 shares

Expires 2036-09-01

F2 · derivative.exercise_date: The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:24 UTC
Hopkins Janet JillChief Medical Officer
GrantCommon Stock 58,850 $0.00 $0.00
Disclosure

SEC source: 0001997710-26-000004 · form4-09012026_090929.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 380,190

F1 · shares: The reported transaction represents a grant of restricted stock units ("RSUs") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:21 UTC
Abu-Absi SusanChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 265,487 $0.00 Strike: $7.43 $0.00
Disclosure

SEC source: 0002148701-26-000008 · form4-09012026_090941.xml · derivative · entry 2

Abu-Absi Susan · CIK 0002148701 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,487

Underlying: Common Stock · 265,487 shares

Expires 2036-09-01

F2 · derivative.exercise_date: The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
September 01, 2026 Filed Sep 1, 2026 21:21 UTC
Abu-Absi SusanChief Operating Officer
GrantCommon Stock 134,513 $0.00 $0.00
Disclosure

SEC source: 0002148701-26-000008 · form4-09012026_090941.xml · nonDerivative · entry 1

Abu-Absi Susan · CIK 0002148701 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,513

F1 · shares: These securities represent an inducement award granted pursuant to a restricted stock unit ("RSU") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027.

Read SEC document
July 07, 2026 Filed Jul 8, 2026 20:11 UTC GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001193125-26-298542 · ownership.xml · derivative · entry 2

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2036-07-07

F2 · derivative.exercise_date: The shares underlying this option vest in three substantially equal annual installments beginning on July 7, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
July 07, 2026 Filed Jul 8, 2026 20:11 UTC GrantCommon Stock 30,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-298542 · ownership.xml · nonDerivative · entry 1

Bender Jeremy · CIK 0001863107 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
July 01, 2026 Filed Jul 1, 2026 20:35 UTC
Kilroy ConorSee Remarks
GrantCommon Stock 14,858 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-292685 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,693

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
June 16, 2026 Filed Jun 16, 2026 20:30 UTC
Gibney Anthony SSee Remarks
SaleCommon Stock 12,824 $6.42 $82,330.08
Disclosure

SEC source: 0001193125-26-272703 · ownership.xml · nonDerivative · entry 1

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,354

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $6.21 $0.00
Disclosure

SEC source: 0001193125-26-271168 · ownership.xml · derivative · entry 5

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-11

F5 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-271168 · ownership.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 194,167

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $6.21 $0.00
Disclosure

SEC source: 0001193125-26-271165 · ownership.xml · derivative · entry 2

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-11

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-271165 · ownership.xml · nonDerivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:31 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $6.21 $0.00
Disclosure

SEC source: 0001193125-26-271171 · ownership.xml · derivative · entry 2

Bitetti Teresa Marie · CIK 0001977608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-11

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:31 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-271171 · ownership.xml · nonDerivative · entry 1

Bitetti Teresa Marie · CIK 0001977608 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $6.21 $0.00
Disclosure

SEC source: 0001193125-26-271170 · ownership.xml · derivative · entry 2

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2036-06-11

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 11, 2026 Filed Jun 15, 2026 20:30 UTC GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-271170 · ownership.xml · nonDerivative · entry 1

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
May 19, 2026 Filed May 19, 2026 20:59 UTC
Holles Natalie C.Director · See Remarks
GrantStock Option (Right to Buy) · Derivative 2,169,103 $0.00 Strike: $7.39 $0.00
Disclosure

SEC source: 0001580111-26-000009 · ownership.xml · derivative · entry 3

Holles Natalie C. · CIK 0001580111 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,169,103

Underlying: Common Stock · 2,169,103 shares

Expires 2036-05-19

F3 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on April 30, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
May 19, 2026 Filed May 19, 2026 20:59 UTC
Holles Natalie C.Director · See Remarks
GrantCommon Stock 553,844 $0.00 $0.00
Disclosure

SEC source: 0001580111-26-000009 · ownership.xml · nonDerivative · entry 2

Holles Natalie C. · CIK 0001580111 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,153,962

F2 · shares: These shares were acquired pursuant to a performance RSU ("PRSU") award as Inducement Awards. The PRSUs are subject to both time-based vesting and the achievement of a performance condition, both of which must be satisfied before the PRSUs will be deemed vested. The PRSUs shall vest in four substantially equal annual installments commencing on April 15, 2027, subject to Ms. Holles' continued service as of each such time-based vesting date and the satisfaction of the performance condition. The expiration date of the PRSUs is the earlier of (i) the sixth (6th) anniversary of the grant date and (ii) the date Ms. Holles no longer has a service relationship with the Issuer. Any such PRSUs that have not vested on or prior to such expiration date shall be forfeited for no consideration.

Read SEC document
May 19, 2026 Filed May 19, 2026 20:59 UTC
Holles Natalie C.Director · See Remarks
GrantCommon Stock 600,118 $0.00 $0.00
Disclosure

SEC source: 0001580111-26-000009 · ownership.xml · nonDerivative · entry 1

Holles Natalie C. · CIK 0001580111 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,118

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award as Inducement Awards. Each RSU represents the right to receive one share of the Issuer's common stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
May 07, 2026 Filed May 11, 2026 20:16 UTC
GOEL DAVID E.10% owner
SaleCommon Stock, par value $0.00001 per share (Common Stock) 6,922,870 $5.64 $39,044,986.80
Disclosure

SEC source: 0000950142-26-001346 · es260777872_4-matrix.xml · nonDerivative · entry 1

Matrix Capital Management Company, LP · CIK 0001410830 · 10% owner

GOEL DAVID E. · CIK 0001548144 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F1 · ownership.nature: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.

F2 · ownership.nature: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
April 16, 2026 Filed Apr 16, 2026 22:49 UTC
Kilroy ConorSee Remarks
SaleCommon Stock 11,738 $7.02 $82,400.76
Disclosure

SEC source: 0001193125-26-159579 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,835

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:06 UTC
Kilroy ConorSee Remarks
GrantStock Option (Right to Buy) · Derivative 112,661 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088170 · ownership.xml · derivative · entry 2

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,661

Underlying: Common Stock · 112,661 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:06 UTC
Kilroy ConorSee Remarks
GrantCommon Stock 62,339 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088170 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,573

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Elazzouzi AmySenior Vice President, Finance
GrantStock Option (Right to Buy) · Derivative 80,472 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088150 · ownership.xml · derivative · entry 2

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,472

Underlying: Common Stock · 80,472 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Elazzouzi AmySenior Vice President, Finance
GrantCommon Stock 44,528 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088150 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 120,060

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 16:06 UTC
de los Pinos ElisabetDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 249,000 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088162 · ownership.xml · derivative · entry 3

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 249,000

Underlying: Common Stock · 249,000 shares

Expires 2036-03-02

F3 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 16:06 UTC
de los Pinos ElisabetDirector · See Remarks
GrantCommon Stock 166,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088162 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 575,815

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:06 UTC
Gibney Anthony SSee Remarks
GrantStock Option (Right to Buy) · Derivative 128,755 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088168 · ownership.xml · derivative · entry 2

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 128,755

Underlying: Common Stock · 128,755 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:06 UTC
Gibney Anthony SSee Remarks
GrantCommon Stock 71,245 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088168 · ownership.xml · nonDerivative · entry 1

Gibney Anthony S · CIK 0001750132 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,178

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Plavsic MarkChief Technology Officer
GrantStock Option (Right to Buy) · Derivative 112,661 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088158 · ownership.xml · derivative · entry 2

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,661

Underlying: Common Stock · 112,661 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Plavsic MarkChief Technology Officer
GrantCommon Stock 62,339 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088158 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,736

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Hopkins Janet JillChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 160,944 $0.00 Strike: $6.14 $0.00
Disclosure

SEC source: 0001193125-26-088154 · ownership.xml · derivative · entry 2

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,944

Underlying: Common Stock · 160,944 shares

Expires 2036-03-02

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Hopkins Janet JillChief Medical Officer
GrantCommon Stock 89,056 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-088154 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 321,340

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 00:48 UTC
Kilroy ConorSee Remarks
SaleCommon Stock 12,079 $5.05 $60,998.95
Disclosure

SEC source: 0001193125-26-055499 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 167,234

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 00:47 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 8,549 $5.06 $43,257.94
Disclosure

SEC source: 0001193125-26-055494 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,532

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 17, 2026 Filed Feb 17, 2026 19:46 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 47,648 $5.06 $241,098.88
Disclosure

SEC source: 0001193125-26-055487 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,815

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 00:47 UTC
Plavsic MarkChief Technology Officer
SaleCommon Stock 15,890 $5.05 $80,244.50
Disclosure

SEC source: 0001193125-26-055497 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,397

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 17, 2026 Filed Feb 18, 2026 00:47 UTC
Hopkins Janet JillChief Medical Officer
SaleCommon Stock 20,401 $5.06 $103,229.06
Disclosure

SEC source: 0001193125-26-055496 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 232,284

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 20, 2026 Filed Jan 20, 2026 23:41 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 1,581 $4.86 $7,683.66
Disclosure

SEC source: 0001193125-26-016939 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,081

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
January 20, 2026 Filed Jan 20, 2026 18:41 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 16,928 $4.86 $82,270.08
Disclosure

SEC source: 0001193125-26-016938 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 457,463

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 17, 2025 Filed Nov 17, 2025 22:56 UTC
Hopkins Janet JillChief Medical Officer
SaleCommon Stock 17,109 $5.42 $92,730.78
Disclosure

SEC source: 0001193125-25-284878 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 252,685

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.42 to $5.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 29, 2025 Filed Oct 29, 2025 21:05 UTC
Elazzouzi AmySenior Vice President, Finance
SaleCommon Stock 896 $6.35 $5,689.60
Disclosure

SEC source: 0001193125-25-256620 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Senior Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,662

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
October 29, 2025 Filed Oct 29, 2025 17:05 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 9,049 $6.35 $57,461.15
Disclosure

SEC source: 0001193125-25-256619 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,391

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document
October 16, 2025 Filed Oct 16, 2025 21:44 UTC
Plavsic MarkChief Technology Officer
SaleCommon Stock 12,169 $6.35 $77,273.15
Disclosure

SEC source: 0001193125-25-241622 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,287

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.